Company intelligence / Profile preview

ENCORE Research Group

Ownership: Private
Development stage: Other

Overview

ENCORE Research Group is an established and widely recognized independent network of multi-specialty clinical research sites in Florida. Since its founding in 1997, it has conducted over 3,200 clinical trials across more than 50 therapeutic areas. In June 2024, it was acquired by Flourish Research to expand national reach and capabilities[2][5].

Industry: Contract Research Organization

Partnerships

Pharmaceutical companies (as sponsors)CROs (Contract Research Organizations)Flourish partnership post-acquisition

Beyond the preview

Go deeper on ENCORE Research Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENCORE Research Group.

Explore the full profile